ASTH · Astrana Health Inc.
$40.31
-0.58% last session
End-of-day data · updated 2026-07-28
Market cap
$2B
Enterprise value
$2B
Trailing P/E
62.6
Forward P/E
11.2
Dividend yield
—
Beta
0.89
Avg volume
1M
Employees
3K
2D change
-5.26%
5D change
-6.83%
10D change
-15.02%
30D change
-14.20%
60D change
1.52%
MTD change
-23.33%
YTD change
53.93%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — ASTH
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-14
Latest call per bank · past 12 months
Barclays
Overweight$50.00
+24.0% vs priceJefferies
Buy$37.00
-8.2% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-14 | TD Cowen | Maintains | Buy | $45.00 → $50.00 |
| 2026-07-14 | BTIG | Maintains | Buy | $50.00 → $65.00 |
| 2026-06-02 | BTIG | Reiterates | Buy | $50.00 |
| 2026-05-26 | Barclays | Upgrade | Equal-Weight → Overweight | $37.00 → $50.00 |
| 2026-05-14 | Truist Securities | Maintains | Buy | $38.00 → $47.00 |
| 2026-05-12 | TD Cowen | Maintains | Buy | $35.00 → $45.00 |
| 2026-05-11 | Barclays | Maintains | Equal-Weight | $26.00 → $37.00 |
| 2026-05-08 | BTIG | Maintains | Buy | $40.00 → $50.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 33 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 8.6% below the 50-day MA ($41.52).
- Price vs 200-day MA: Trading 25.6% above the 200-day MA ($30.23).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-1.32) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($18.16) and high ($49.81).
ASTH Price Chart
Loading chart for ASTH…
Fundamentals
About Astrana Health Inc.
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.
More in Medical Care Facilities
HCA
HCA Healthcare, Inc.
$86B -16.3% YTD
THC
Tenet Healthcare Corporation
$21B 22.5% YTD
DVA
DaVita Inc.
$15B 108.0% YTD
FMS
Fresenius Medical Care AG
$13B 8.6% YTD
EHC
Encompass Health Corporation
$11B 7.9% YTD
UHS
Universal Health Services, Inc.
$10B -26.8% YTD
ENSG
The Ensign Group, Inc.
$10B 2.3% YTD
CHE
Chemed Corp
$7B 19.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.